EDGAR Filing Documents for 0001213900-23-054243

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]

SEC Accession No. 0001213900-23-054243

Filing Date

2023-07-05

Accepted

2023-07-03 19:09:16

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT NO. 1 TO FORM F-1	ea180891-f1a1_altamira.htm	F-1/A	426520
2	FORM OF COMMON WARRANT	ea180891ex4-19_altamira.htm	EX-4.19	109932
3	FORM OF PRE-FUNDED WARRANT	ea180891ex4-20_altamira.htm	EX-4.20	104950
4	FORM OF PLACEMENT AGENT WARRANT	ea180891ex4-21_altamira.htm	EX-4.21	102819
5	OPINION OF CONYERS DILL & PEARMAN LIMITED, BERMUDA COUNSEL TO THE COMPANY, AS TO	ea180891ex5-1_altamira.htm	EX-5.1	32239
6	OPINION OF LOWENSTEIN SANDLER LLP, U.S. COUNSEL TO THE COMPANY, AS TO THE VALIDI	ea180891ex5-2_altamira.htm	EX-5.2	7645
7	FORM OF SECURITIES PURCHASE AGREEMENT	ea180891ex10-44_altamira.htm	EX-10.44	292663
8	CONSENT OF DELOITTE AG	ea180891ex23-1_altamira.htm	EX-23.1	2532
9	GRAPHIC	image_001.jpg	GRAPHIC	3519
10	GRAPHIC	ex5-1_001.jpg	GRAPHIC	4314
	Complete submission text file	0001213900-23-054243.txt		1091685

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000

Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000 41 (0) 41 729 71 94

Altamira Therapeutics Ltd. (Filer) CIK: 0001601936 (see all company filings)